Dean Gray

Dean Gray Email and Phone Number

Medtech and Healthtech Executive, Board Director and Strategic Advisor @ WARD 24/7
Dean Gray's Location
Boston, Massachusetts, United States, United States
Dean Gray's Contact Details
About Dean Gray

With more than 30 years of experience in the healthcare industry, I am a growth strategist who helps MedTech, HealthTech companies to create and deliver breakthrough solutions that improve patient care, outcomes, and clinical workflow. I have a track record of delivering transformative healthcare products and accelerating growth for companies in the US, Europe, and Asia across a broad range of diagnostic and therapeutic applications. I have a deep knowledge of customer needs and solutions in a range of diseases and therapeutic areas, with a particular focus on companion diagnostics and biomarkers, diagnostic imaging, surgical solutions and robotics, endoscopic therapeutic interventions, remote patient monitoring, and AI-enabled solutions for productivity and workflow optimization, automated image analysis, and clinical decision support.I also serve as a board director and strategic advisor for several HealthTech start-ups that are developing innovative tools for rapid detection of dementia, remote patient monitoring/early warning systems, and clinical decision support. My mission is to leverage my expertise in innovation, strategy, and marketing to enable patients and healthcare providers to benefit from the latest advances in science, technology, and medicine.

Dean Gray's Current Company Details
WARD 24/7

Ward 24/7

View
Medtech and Healthtech Executive, Board Director and Strategic Advisor
Dean Gray Work Experience Details
  • Ward 24/7
    Member Board Of Directors
    Ward 24/7 May 2023 - Present
    Copenhagen, Capital Region Of Denmark, Dk
    WARD 24/7 is a HealthTech company enabling floor nurses to better anticipate and prevent critical clinical events by transforming patient monitoring practice and technology into an "early warning" system. Based on continuous real-time wireless vital sign monitoring, WARD’s proprietary AI / ML algorithms and smart device solution seamlessly generate new insights that recognize patient clinical deterioration early enough to prevent unexpected and often fatal events such as stroke and sepsis.
  • Nordic Mentor Network For Entrepreneurship - Nome
    Board Member Selection Committee And Mentor, Nome
    Nordic Mentor Network For Entrepreneurship - Nome Mar 2018 - Present
    Copenhagen, Capital Region, Dk
    • Board Member Selection Committee at NOME, mentoring life science startups in the Nordic region.• Collaborated with high-profile executives to provide strategic advice and support to life science and healthcare startups.• Contributed to the success of NOME by selecting top-tier startups for mentorship and funding opportunities.
  • Cognes
    Strategic Advisor
    Cognes Apr 2023 - Present
    Cognes is developing a non-invasive, smart device-based tool for rapid detection of dementia. Using novel insights from computer vision analysis of facial expressions coupled with cognitive assessment tests, we enable early detection of cognitive impairment and dementia for clinical research and ultimately in routine clinical care for anyone, anywhere.
  • Lsc - Lifesciences Consultants
    Partner
    Lsc - Lifesciences Consultants Jul 2023 - Aug 2024
    San Francisco - Jersey City - Mexico City - Milan - Zug , Oo
    LSC is a global life sciences strategy consultancy with 20 years track record of helping clients to successfully deliver transformative healthcare products and accelerate growth. We build value for clients, healthcare providers, and patients in the US, Europe, and Emerging Markets.I provide a range of services to assist MedTech, Digital Health, Biopharma, and Investor clients to better understand and value new growth opportunities that improve patient care in a digitally connected world. I develop actionable product and business growth, Go-to-Market, and market entry strategies and plans to bring new products and solutions to market quickly and rapidly scale.I am specially focused on helping clients to:✅ Understand the healthcare market and patient journey to identify unseen opportunities to solve big clinical problems, improve outcomes, and provide value to their customers, patients and investors.✅ Define and validate the clinical benefit and economic value of their diagnostic and therapeutic products and digital solutions.✅Generate evidence that substantiates the value of advanced technology and digital tools to both clinical and non-clinical stakeholders.✅Act on the promise of remote patient monitoring (RPM) and AI-powered personalized medicine to provide early clinical insights, enhance the patient experience, and deliver better healthcare for all patient communities.
  • Pa Consulting
    Partner, Member Of Pa'S Management Group, Global Lead Surgery, Pride Erg Executive Sponsor
    Pa Consulting Aug 2021 - Apr 2023
    London, London, Gb
    Provided product ideation and validation and end-to-end multidisciplinary product development and commercialization services to assist global MedTech and HealthTech clients accelerate innovation and growth of digitally connected device-data products and system-wide solutions. Focused on digital surgical solutions and robotics, biosensors and smart devices, mobile health apps, AI-enabled analytics, diagnostic imaging, and digital biomarkers.RESULTS ♦ For leading MedTech strategic, determined commercial opportunity, created value proposition, defined technical requirements, developed growth strategy and business model for novel AI-enabled visualization and data analytics minimally invasive surgical platform which de-risked investment, accelerated market entry, and increased franchise revenue and profitability.
  • Technology Commercialization Group (Tcg)
    Partner
    Technology Commercialization Group (Tcg) 2017 - Aug 2021
    Raleigh, Nc, Us
    TCG provides strategic advisory, partnering, BD&L and interim management services to help life science companies grow. Selected clients include: Curasan, Humedics, Materialise, OptiScan Imaging, OssoForm, Polarean, Ricoh, Rotem, Tyromotion, Voxeleron.RESULTS♦ For key client, successfully repositioned novel drug/device combination diagnostic product from organ transplant applications to larger opportunity in clinical assessment of NASH and chronic liver disease.
  • Appareo
    Principal
    Appareo 2014 - 2017
    Co-led consulting firm to provide expertise on product portfolio assessment/planning and go-to-market strategies for diagnostic imaging and medtech companies. Selected clients include Optovue, Quantel, Voxeleron, Lumedica, and Luneau Technology.RESULTS♦ Developed and commercialized optical coherence tomography angiography retinal candidate biomarker of Alzheimer’s disease for key client resulting in accelerated publications, clinical validation, and pharma company engagement.
  • Heidelberg Engineering
    Vice President And General Manager, Neurology Division
    Heidelberg Engineering 2003 - 2014
    Heidelberg, Baden-Württemberg, De
    General management/P&L responsibility for neurology-focused business unit. Led product design and development, go-to-market strategy and commercialization efforts including academic collaborations, protocol design and clinical validation, investment and partnering, regulatory, reimbursement, and sales and marketing efforts for novel retinal biomarker with >$350 million potential in multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative diseases. Served as interim business unit head.RESULTS♦ Achieved pharma and clinical neurology sales of $5 million beta product revenue in first two years.
  • Sanofi Genzyme
    Vice President, Global Marketing, Bio-Orthopedics
    Sanofi Genzyme 2001 - 2003
    Paris, France, Fr
    Led growth of $120 million product line. Developed clinical outcome-oriented sales, marketing, customer education and reimbursement programs to accelerate adoption of cartilage replacement product, the first biologic implant approved in the U.S. Managed marketing alliance for viscoelastic product with Wyeth. Evaluated additional indications and buy-back of marketing rights with upside of $350 million. RESULTS♦ Increased growth of $120 million product line by +15% in one year.
  • Boston Scientific
    Vice President, Microvasive Urology
    Boston Scientific 1999 - 2001
    Marlborough, Ma, Us
    Established and led first dedicated global strategic planning and product group for $200 million division. Identified four new growth markets, expanded product portfolio and implemented plan to double revenues to $325 million over three years. Built strong group of product directors, market research professionals and forecasters across multiple specialties.RESULTS♦ Achieved 80% of aggressive five-year growth goal in less than two years.
  • Boston Scientific
    Vice President, International
    Boston Scientific 1996 - 1999
    Marlborough, Ma, Us
    Set direction and managed execution of company’s international expansion for gastroenterology and urology businesses. Developed strategy, designed and built marketing and selling organizations in Europe and Asia, planned and executed new product launches, identified unmet customer needs and developed new products. RESULTS♦ Increased revenue from $23 million to $111 million and expanded market share (24% to 60% for endoscopy and 8% to 23% for urology) in three years.
  • Bd
    General Manager, Surgical
    Bd 1993 - 1996
    Franklin Lakes, New Jersey, Us
    General management/P&L responsibility for $50 million North American business unit. Led sales/marketing, manufacturing, R&D, and supply chain activities of +200 employees at three facilities in US, Canada and Mexico. Developed, obtained patent approvals, and launched four novel antimicrobial drug formulations. RESULTS♦ Increased market share by 14% points to 74%. Improved operating profit by 89% over prior year to $4.7 million (15% of sales). Increased RONA to 20% from 11%.
  • Bd
    Director, International Marketing
    Bd 1991 - 1993
    Franklin Lakes, New Jersey, Us
    Planned and executed start-up of international business for $150 million surgical products division. RESULTS♦ $15 million sales in first year and grew revenue over 50% per year in following two years.
  • Pfizer (Formerly American Cyanamid/Lederle/Wyeth)
    Regional Business Director - Asia
    Pfizer (Formerly American Cyanamid/Lederle/Wyeth) 1988 - 1991
    New York, New York, Us
    Led regional subsidiaries business and new product launch activities. Led negotiations for $15 million joint-venture agreement with Chinese partner, obtained CEO and BOD approval, provided entry to emerging China market and first steps toward $100 million opportunity.RESULTS♦ 16% sales increase to $120 million, and improved operating profit margins by 10% points in first year.

Dean Gray Skills

Commercialization Medical Devices Global Marketing Strategy Market Development Product Launch Life Sciences Strategic Planning Biotechnology Start Ups Business Development Pharmaceutical Industry Product Development International Sales Neurology Management Marketing Cross Functional Team Leadership Market Analysis Clinical Research New Business Development Leadership Business Strategy Entrepreneurship Capital Equipment Clinical Trials Marketing Strategy Pharmaceuticals R&d Cardiology Oncology International Business Sales Market Research Product Management Sales Operations Forecasting Fda P&l Management Business Planning Competitive Analysis Management Consulting Executive Management Product Marketing Diagnostics International Management Marketing Management Strategic Consulting Strategy Development Sales Management

Dean Gray Education Details

  • Columbia University
    Columbia University
    International Business
  • Earlham College
    Earlham College
    Political Science
  • Middlebury College
    Middlebury College
    Japanese

Frequently Asked Questions about Dean Gray

What company does Dean Gray work for?

Dean Gray works for Ward 24/7

What is Dean Gray's role at the current company?

Dean Gray's current role is Medtech and Healthtech Executive, Board Director and Strategic Advisor.

What is Dean Gray's email address?

Dean Gray's email address is de****@****ech.com

What schools did Dean Gray attend?

Dean Gray attended Columbia University, Earlham College, Middlebury College.

What are some of Dean Gray's interests?

Dean Gray has interest in Environment.

What skills is Dean Gray known for?

Dean Gray has skills like Commercialization, Medical Devices, Global Marketing, Strategy, Market Development, Product Launch, Life Sciences, Strategic Planning, Biotechnology, Start Ups, Business Development, Pharmaceutical Industry.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.